We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
J&J Licenses Hep B Treatments from Chinese Drugmaker
Stealth BioTherapeutics Wins Fast Track Designation for MTP-131
Galera Snatches Up FDA Fast Track for Oral Mucositis Candidate
Checkpoint Licenses Cancer Therapies from Teva
BLA Expected in Early 2016 After Dynavax’s Hepatitis B Vaccine Meets Primary Endpoints